{"id":78042,"date":"2024-10-01T03:50:11","date_gmt":"2024-10-01T11:50:11","guid":{"rendered":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/2024\/10\/01\/pharma-company-gets-fda-green-light-for-next-phase-trial-for-tourette-syndrome\/"},"modified":"2024-10-01T04:45:37","modified_gmt":"2024-10-01T12:45:37","slug":"pharma-company-gets-fda-green-light-for-next-phase-trial-for-tourette-syndrome","status":"publish","type":"post","link":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/2024\/10\/01\/pharma-company-gets-fda-green-light-for-next-phase-trial-for-tourette-syndrome\/","title":{"rendered":"Pharma Company Gets FDA Green Light For Next Phase Trial For Tourette Syndrome"},"content":{"rendered":"<p> Pharma Company Gets FDA Green Light For Next Phase Trial For Tourette Syndrome<\/p>\n<p>      Image<\/p>\n<p>Cannabis News<br \/>\nOctober 1, 2024<\/p>\n<p>              SciSparc receives FDA approval for a Phase IIb trial of a cannabinoid based treatment for Tourette Syndrome. SciSparc Ltd., a clinical-stage pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has approved its investigational new drug (IND), which enables the company<\/p>\n<p>        Cannabis Technology News<\/p>\n<p>        by Rolando Garcia&#013;<br \/>\n&#013;<br \/>\nRead More: <a href=\"https:\/\/420intel.com\/articles\/2024\/10\/01\/pharma-company-gets-fda-green-light-next-phase-trial-tourette-syndrome\" target=\"_blank\" rel=\"noopener\">Pharma Company Gets FDA Green Light For Next Phase Trial For Tourette Syndrome<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pharma Company Gets FDA Green Light For Next Phase Trial For Tourette Syndrome Image Cannabis News October 1, 2024 SciSparc receives FDA approval for a Phase IIb trial of a cannabinoid based treatment for Tourette Syndrome. SciSparc Ltd., a clinical-stage pharmaceutical company, announced that the U.S. Food and Drug Administration<span class=\"more-link\"><a href=\"https:\/\/cannabiscultivatornews.com\/home\/index.php\/2024\/10\/01\/pharma-company-gets-fda-green-light-for-next-phase-trial-for-tourette-syndrome\/\">Continue Reading<\/a><\/span><\/p>\n","protected":false},"author":535,"featured_media":0,"comment_status":"false","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/78042"}],"collection":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/users\/535"}],"replies":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/comments?post=78042"}],"version-history":[{"count":1,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/78042\/revisions"}],"predecessor-version":[{"id":78043,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/78042\/revisions\/78043"}],"wp:attachment":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/media?parent=78042"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/categories?post=78042"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/tags?post=78042"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}